GlobeNewsWire
26 Sept 2026, 17:26 UTC · 4h ago
Verdict
Headline leans bearish. We score CAPR −0.90 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.90strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
The FDA extended the PDUFA target action date for deramiocel from August 22, 2026, to November 22, 2026.
Priced inannounced Aug 24
So whatThe 3-month delay pushes the binary approval catalyst into Q4 2026, extending the period of cash burn without commercial revenue.
More negative than 85% of claims this week
Capricor requested to pivot its BLA toward a refined indication focused solely on upper limb function.
Continue reading
5 related stories
More negative than 89% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Priced inannounced Aug 24
So whatNarrowing the indication typically reduces the addressable patient population, which may lower peak sales estimates and the company's valuation multiple.
More negative than 77% of claims this week
Investors have until September 28, 2026, to apply for lead plaintiff status in a securities class action lawsuit.
Newpress release dated Sept 26
So whatWhile litigation is ongoing, a successful lead plaintiff appointment within the next 48 hours can accelerate the discovery process and legal costs.
More negative than 63% of claims this week
Which stocks this story touches
More negative than 89% of ticker scores this week
The company is facing a shareholder class action lawsuit following an FDA review extension and alleged misleading disclosures.
More negative than 80% of ticker scores this week
The company is mentioned as the subject of investor losses due to allegedly misleading financial statements.
More negative than 80% of ticker scores this week
The company is mentioned as the subject of investor losses due to allegedly misleading financial statements.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
8h ago
—
CAPR hasn't traded since this ran. Last close $8.36 (Sep 25); the reaction starts at the next open.
CAPR chart →
